VFA
APLT

Valeo Financial Advisors’s Applied Therapeutics APLT Stock Holding History

Valeo Financial Advisors’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-77
Closed -$2K – 1672
2020
Q3 		$2K Buy
+77
New +$2K ﹤0.01% 1383

Other funds holding APLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Valeo Financial Advisors's APLT Position: Q4 2020 in Review

Valeo Financial Advisors sold out of Applied Therapeutics (APLT) in Q4 2020, closing a stake of 77 shares — an estimated $2K sold.

Valeo Financial Advisors first reported a position in APLT in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 67 funds tracked by Wall St. Rank hold APLT as of Q4 2020.

  • Valeo Financial Advisors reported no remaining Applied Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 77 Applied Therapeutics shares in Q4 2020, an estimated $2K.
  • Valeo Financial Advisors first reported a position in Applied Therapeutics in Q3 2020 and held it in 1 quarter.
  • Valeo Financial Advisors's Applied Therapeutics position peaked at $2K in Q3 2020.
  • 67 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2020.

Based on Valeo Financial Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.